Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Vir Biotechnology (NASDAQ: VIR) has announced that CEO Marianne De Backer will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Tuesday, January 14, at 4:30 p.m. PT.
Interested parties can access a live webcast of the presentation through the Events & Presentations section of Vir's investor relations website at www.vir.bio. The webcast recording will remain available on the website for 30 days following the presentation.
Vir Biotechnology (NASDAQ: VIR) ha annunciato che il CEO Marianne De Backer terrà una presentazione alla 43ª Conferenza annuale J.P. Morgan Healthcare a San Francisco. La presentazione è programmata per martedì 14 gennaio, alle 16:30 PT.
Le parti interessate possono accedere a un webcast dal vivo della presentazione attraverso la sezione Eventi e Presentazioni del sito web per gli investitori di Vir all'indirizzo www.vir.bio. La registrazione del webcast rimarrà disponibile sul sito per 30 giorni dopo la presentazione.
Vir Biotechnology (NASDAQ: VIR) ha anunciado que la CEO Marianne De Backer realizará una presentación en la 43ª Conferencia Anual de J.P. Morgan sobre Salud en San Francisco. La presentación está programada para el martes 14 de enero, a las 16:30 PT.
Las partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Eventos y Presentaciones en el sitio web de relaciones con inversores de Vir en www.vir.bio. La grabación del webcast estará disponible en el sitio durante 30 días después de la presentación.
Vir Biotechnology (NASDAQ: VIR)는 CEO Marianne De Backer가 샌프란시스코에서 열리는 제43회 JP 모건 헬스케어 컨퍼런스에서 발표를 할 것이라고 발표했습니다. 발표는 1월 14일 화요일 오후 4시 30분 PT로 예정되어 있습니다.
관심 있는 당사자는 Vir의 투자자 관계 웹사이트 www.vir.bio의 이벤트 및 프레젠테이션 섹션을 통해 실시간 웹캐스트에 접근할 수 있습니다. 웹캐스트 녹화는 발표 후 30일 동안 웹사이트에서 이용할 수 있습니다.
Vir Biotechnology (NASDAQ: VIR) a annoncé que la CEO Marianne De Backer fera une présentation lors de la 43e Conférence Annuelle de J.P. Morgan sur la Santé à San Francisco. La présentation est prévue pour le mardi 14 janvier, à 16h30 PT.
Les parties intéressées peuvent accéder à un webcast en direct de la présentation via la section Événements et Présentations du site web des relations investisseurs de Vir à l'adresse www.vir.bio. L'enregistrement du webcast restera disponible sur le site pendant 30 jours après la présentation.
Vir Biotechnology (NASDAQ: VIR) hat bekannt gegeben, dass CEO Marianne De Backer eine Präsentation auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco halten wird. Die Präsentation ist für Dienstag, den 14. Januar, um 16:30 Uhr PT geplant.
Interessierte Parteien können über den Bereich Veranstaltungen und Präsentationen auf der Investor-Relations-Website von Vir unter www.vir.bio auf einen Live-Webcast der Präsentation zugreifen. Die Aufzeichnung des Webcasts bleibt 30 Tage nach der Präsentation auf der Website verfügbar.
- None.
- None.
A live webcast of the presentation will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple double-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology routinely posts information that may be important to investors on its website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241217582851/en/
Media
Arran Attridge
Senior Vice President, Corporate Communications
aattridge@vir.bio
Investors
Richard Lepke
Senior Director, Investor Relations
rlepke@vir.bio
Source: Vir Biotechnology, Inc.
FAQ
When is Vir Biotechnology (VIR) presenting at the J.P. Morgan Healthcare Conference?
How can I watch Vir Biotechnology's (VIR) J.P. Morgan Healthcare Conference presentation?
Who is presenting for Vir Biotechnology (VIR) at the J.P. Morgan Healthcare Conference?
How long will Vir Biotechnology's (VIR) J.P. Morgan presentation be available for replay?
